Which drug, when given with a monoamine oxidase inhibitor type B (MAOI-B), can have a positive effect in a patient with Parkinson's disease? Levodopa Dextromethorphan Methadone Sympathomimetic amines

When given alongside a monoamine oxidase inhibitor type B (MAOI-B), Levodopa can significantly boost the treatment for patients with Parkinson's disease. Levodopa is a precursor to dopamine, helping to replenish the brain's dopamine levels, which are typically low in those suffering from Parkinson's. The combination works synergistically, enabling better management of motor symptoms associated with the disease. However, one must always proceed with caution! While the combination can be beneficial, there is also a risk of hypertensive crises due to the potential increase in catecholamines. It’s crucial for patients and caregivers to monitor blood pressure and consult with healthcare professionals before making any changes to treatment plans.